cysteine protease inhibitors (NAEJA)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namecysteine protease inhibitors (NAEJA)
Drug Alias Namecathepsin S inhibitors (Naeja)CPIs (British Biotech/SynPhar)cathepsin K inhibitors (Naeja)cysteine proteinase inhibitors (British Biotech/SynPhar)NPI-2349 +[12] 
ClassificationSmall molecules
Mechanisms of ActionCathepsin S inhibitorsCathepsin B inhibitorsCathepsin K inhibitors +[4] 
TargetsCathepsin SCathepsin BCathepsin L +[4] 
Therapy Area/IndicationsAsthmaOsteoarthritisArthritis, Rheumatoid +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNaeja Pharmaceutical Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNaeja Pharmaceutical IncVernalis Plc
Active IndicationsN/A
Inactive IndicationsAsthmaOsteoarthritisArthritis, Rheumatoid +[5] 

Other Information

ATC CodeN/A
Related LinksN/A